ProfileGDS4132 / 231372_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 34% 34% 38% 40% 39% 25% 38% 34% 34% 35% 38% 34% 38% 40% 35% 42% 33% 34% 37% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10185.31234
GSM201543Muscle PCOS pioglitazone 12177.230634
GSM201544Muscle PCOS pioglitazone 161100.71638
GSM201545Muscle PCOS pioglitazone 201110.07640
GSM201829Muscle PCOS pioglitazone 231107.48439
GSM201830Muscle PCOS pioglitazon 25159.025125
GSM201831Muscle PCOS pioglitazone 27196.40138
GSM201832Muscle PCOS pioglitazone 3185.072534
GSM201833Muscle PCOS pioglitazone 4179.788634
GSM201834Muscle PCOS pioglitazone 8187.319935
GSM201835Muscle PCOS after pioglitazone 10283.259438
GSM201836Muscle PCOS after pioglitazone 12275.352834
GSM201837Muscle PCOS after pioglitazone 16281.903138
GSM201838Muscle PCOS after pioglitazone 20291.965440
GSM201839Muscle PCOS after pioglitazone 23280.139535
GSM201840Muscle PCOS after pioglitazone 252103.76642
GSM201841Muscle PCOS after pioglitazone 27268.799533
GSM201842Muscle PCOS after pioglitazone 3267.64934
GSM201843Muscle PCOS after pioglitazone 4291.750137
GSM201844Muscle PCOS after pioglitazone 8299.279440